FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Pentagon's vaunted F-35 earns lousy review from test pilot in secret report|
|How would the military’s new F-35 Joint Strike Fighter aircraft fare in a dogfight against an old F-16D fighter? Not well, according to a leaked test pilot report of mock air battles in January between the two aircraft.|
|Failure Is Not the End. It's an Opportunity to Learn.|
|Failure is an external event that happens. It is not a personality characteristic.|
|Menendez prosecutors seek hearing on evidence, citing possible national security concerns|
|Prosecutors in the corruption case against Sen. Bob Menendez have asked a judge to hold a hearing to determine whether some evidence should be withheld or restricted due to possible national security concerns.|
|Inmate injured after 3-week escape still hospitalized; no service planned for slain partner|
|A prison inmate shot and captured after three weeks on the run in northern New York remained hospitalized Friday while the body of his fellow escapee was handled in accordance with the wishes of his son.|
|Judge allows Aaron Hernandez defense to subpoena Verizon in effort to ID anonymous caller|
|A Massachusetts judge has authorized a subpoena so lawyers for former New England Patriots player Aaron Hernandez can identify an anonymous tipster who claimed one of the jurors who convicted Hernandez of murder may have been "untruthful" during jury selection.|
|Mass. authorities seek to ID toddler in 'Baby Doe' mystery|
|Investigators in Massachusetts are seeking the public’s help to solve a horrific mystery and identify a little girl whose body was found in a trash bag on the shoreline of a Boston Harbor island.|
|How Growing Up With the Internet Made Millennials Different|
|The generation dubbed "digital natives'' prefer YouTube to TV and the World Cup to bowl games. Marketers need to adapt.|
|Prosecutors say 79-year-old accounting executive earned leniency in Madoff case by cooperating|
|Prosecutors say a 79-year-old former New York accounting firm executive who did work for some of Bernard Madoff's most important longtime clients has earned leniency by cooperating.|
|Florida homeless ex-Marine piano man draws raves playing Bach, Styx|
|A homeless ex-Marine has got passersby feeling alright in downtown Sarasota, Fla., as he plays Bach, the Beatles and Styx on sidewalk pianos.|
|What the Color of Your Logo Says About Your Company (Infographic)|
|The Golden Arches just wouldn't communicate the same thing if they were purple.|